Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE7661.3060.55 (+0.8 %)

PREV CLOSE ( ) 7600.75

OPEN PRICE ( ) 7558.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2908

TODAY'S LOW / HIGH ( )7452.55 7777.85

52 WK LOW / HIGH ( )2006 7794

NSE7668.5075.05 (+0.99 %)

PREV CLOSE( ) 7593.45

OPEN PRICE ( ) 7700.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 7668.50 (291)

VOLUME 27645

TODAY'S LOW / HIGH( ) 7461.80 7763.95

52 WK LOW / HIGH ( )2009.05 7790

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984

Management Info

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

30Apr Neuland Laboratories informs about ear
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

03Apr Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..

04Mar Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..

26Feb Neuland Laboratories informs about iss
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Di..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	807.01	1631.19
Gross Profit	1037.8	2152.13
Operating Profit	1226.65	2810.56
Net Sales	3928.28	11911.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE) 8679.45 (4.27%)	M.Cap ( in Cr)19989.31
Abbott India (BSE) 26604.35 (0.71%)	M.Cap ( in Cr)56532.39
Amrutanjan Healthcar (BSE) 786.60 (12.70%)	M.Cap ( in Cr)2274.11
NGL Fine-Chem (BSE) 2634.60 (3.41%)	M.Cap ( in Cr)1627.66
Dr. Reddy's Lab (BSE) 6288.30 (1.34%)	M.Cap ( in Cr)104900.33

Shareholding Pattern

	NON-INSTITUTION	35.88%
	PROMOTERS	32.74%
	MUTUAL FUNDS/UTI	3.88%
	GOVERNMENT	0.4%
	FI/BANKS/INSURANCE	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal Nifty...	1.00
Bandhan Small Cap F...	0.74
WOC ELSS Tax Saver ...	0.70
WOC Multi Cap Fund-Reg(G)	0.68
WOC Flexi Cap Fund-Reg(G)	0.60
Motilal Oswal S&P B...	0.52
WOC Mid Cap Fund-Reg(G)	0.51

Risk Disclosures on Derivatives

Smart Quotes

NEULAND LABORATORIES LTD.